Trelegy Ellipta (fluticasone furoate/umeclidinium bromide/vilanterol) / Innoviva, Royalty, GSK, Theravance Biopharma  >>  Phase 4
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Trelegy Ellipta (fluticasone furoate/umeclidinium bromide/vilanterol) / GSK, Innoviva, Theravance Biopharma
NCT05535972: To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD

Completed
4
460
RoW
FF/UMEC/VI, TRELEGY ELLIPTA
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
09/23
09/23
Sundial-COPD, NCT05292053: Outcomes of Once-Daily ICS/LABA/LAMA Plus PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations

Not yet recruiting
4
80
US
TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
Baylor Research Institute
Copd
08/23
09/23
ANTES B+, NCT06282861: Clinical Trial

Recruiting
4
1028
Europe
Trelegy Ellipta 100/62.5/25Mcg Inh 30D, LABA/LAMA/ICS, Brimica, LABA/LAMA, Duaklir, Ultibro, Ulunar, Xoterna, Anoro, Laventair, Spiolto Respimat, Yanimo, Foradil, LABA, Broncoral, Formoterol stada, Oxis, Formatris, Formoterol Aldo, Onbrez, Oslif, Hirobriz, Striverdi, Beglan, Betamican, Inaspir, Serevent, Soltel, Eklira, LAMA, Bretaris, Seebri, Tovanor, Enurev, Spiriva, Tavulus, Sirkava, Braltus, Gregal, Incruse, Rolufta
Fundacio Privada Mon Clinic Barcelona, GlaxoSmithKline
Chronic Obstructive Pulmonary Disease
09/25
09/25
NCT06372496: Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

Recruiting
4
1136
Canada, Japan, US, RoW
Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate, Inhaled corticosteroids/long-acting beta-2 agonists
GlaxoSmithKline
Asthma
03/26
03/26
NCT04923347: A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Completed
4
229
RoW
FF/UMEC/VI, ELLIPTA
GlaxoSmithKline
Pulmonary Disease, Chronic Obstructive
03/24
03/24

Download Options